Skip to main content
SpringerLink
Log in

When should general practitioners administer thrombolytics?

  • New Drugs and Therapeutic
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rawles J. Guidelines for general practitioners administering thrombolytics. Drugs 1995 Oct; 50(4): 615–25

    Article  PubMed  CAS  Google Scholar 

  2. Weston CFM, Penny WJ, Julian DG, on behalf of the British Heart Foundation working group. Guidelines for the early management of patients with myocardial infarction. Br Med J 1994 Mar 19;308: 767–71

    Article  CAS  Google Scholar 

  3. British National Formulary No. 30. London: The Pharmaceutical Press, 1995 Sep; 108–9

  4. Hannaford P, Vincent R, Ferry S, et al. Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners. Br J Gen Pract 1995 Apr; 45: 175–9

    PubMed  CAS  Google Scholar 

  5. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. Br Med J 1992; 305: 548–53

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

When should general practitioners administer thrombolytics?. Drugs Ther. Perspect 7, 10–13 (1996). https://doi.org/10.2165/00042310-199607080-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607080-00004

Search

Navigation